Maravai LifeSciences Holdings, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $24.1M | $7.0M | $17.1M | $1.7M |
| FY2020 | $152.2M | $126.8M | $25.4M | $24.6M |
| FY2021 | $368.6M | $353.7M | $14.9M | $10.5M |
| FY2022 | $536.0M | $518.9M | $17.1M | $18.7M |
| FY2023 | $126.2M | $60.7M | $65.6M | $34.6M |
| FY2024 | $7.5M | $-22.2M | $29.7M | $49.4M |
| FY2025 | $-57.6M | $-70.7M | $13.1M | $30.2M |